Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors

J. Ducore, J. B. Lawrence, M. Simpson, L. Boggio, A. Bellon, J. Burggraaf, J. Stevens, M. Moerland, J. Frieling, J. Reijers, M. Wang

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences